2-(PYRIDIN-3-YLOXY)ETHANAMINE HCL, 95.0%, 10g

3-(2-methoxyphenyl)-4-(4-methylphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 95+%, 100mg

N-[3,5-Bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide, 98%, 50mg

Methyl 12-aminododecanoate hydrochloride, 95%, 1g

4-((4-Fluorophenyl)amino)-4-oxobutanoic acid, 95+%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-methyl-1H-indol-3-yl)propanoic acid, 98+%, 1g

2,5-Diiodobenzoic acid, 98.0%, 100g

Methyl trans-4-Hydroxycyclohexanecarboxylate, 98.0%, 25g

Syringe filters Millex® Polyvinylidene fluoride (PVDF), 0,45 µm, 13 mm, Millex® HV with extended outlet, 100 Piece(s)

N,N'-Bis(4-methoxy-2-methylphenyl)-N,N'-diphenylbenzidine (purified by sublimation)>98.0%(HPLC)(N)5g

2,5-Bis(2-octyldodecyl)-3,6-bis(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, 97%, 1g

1,3-Bis(hydroxymethyl)urea>97.0%(N)500g

7-Bromo-4-methoxyquinoline, 95.0%, 1g